C-Raven for Smoking Addiction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help people quit smoking using a virtual counselor called C-Raven (a digital support tool) and support from a community health worker. The goal is to determine if this approach aids smoking cessation and encourages lung cancer screening. Participants will be divided into two groups: one will receive the intervention immediately, while the other will start after six months. The trial seeks individuals who are 50 or older, currently smoke, and are considering quitting. As a Phase 4 trial, this study involves an FDA-approved treatment and aims to understand its benefits for more patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What is the safety track record for C-Raven?
Research has shown that virtual programs like C-Raven, which assist people in quitting smoking, are generally safe and easy to use. Similar treatments in past studies were well-tolerated, with users often experiencing only minor side effects. Although specific side effect information for C-Raven isn't provided, its testing in a Phase 4 trial suggests a strong safety record. Phase 4 trials typically focus on treatments already approved for public use, indicating they were found safe in earlier studies.12345
Why are researchers enthusiastic about this study treatment?
Researchers are excited about C-Raven for smoking addiction because it combines advanced virtual counseling with the support of a community health worker, setting it apart from traditional options like nicotine replacement therapies and medications. This approach emphasizes personalized support and shared decision-making, which can empower participants to make informed choices about their health. Additionally, the integration of lung cancer screening discussions introduces a comprehensive health management strategy, potentially enhancing motivation to quit smoking.
What evidence suggests that the C-Raven intervention is effective for smoking addiction?
Research shows that C-Raven, a virtual program designed to help people quit smoking, uses a computerized avatar counselor to support users. In this trial, participants in one arm will receive the C-Raven program, support from community health workers, and access to nicotine replacement products. Although specific success rates for C-Raven are not yet available, the combination of virtual counseling and community support is believed to facilitate quitting smoking. Studies have indicated that similar programs can improve success rates by offering personalized help and advice. This approach has been tested in other trials, which showed promising results in encouraging people to engage and quit smoking in the short term.23467
Who Is on the Research Team?
Alejandra Ellison-Barnes, MD
Principal Investigator
Johns Hopkins School of Medicine
Are You a Good Fit for This Trial?
This trial is for individuals struggling with nicotine or smoking addiction and are patients at a residency clinic in Baltimore. Participants should be interested in quitting smoking and willing to try virtual counseling, possibly use nicotine replacement products, and undergo lung cancer screening.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial evaluation including demographics, clinical history, and tobacco use history
Treatment
Participants receive computer-delivered counseling and nicotine replacement therapy
Follow-up
Participants are monitored for smoking cessation outcomes and intervention acceptability
What Are the Treatments Tested in This Trial?
Interventions
- C-Raven
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Maryland Cigarette Restitution Fund
Collaborator